Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,023 across all filing types
Latest filing 2013-03-05 Earnings Release
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
UCB Vimpat US Monotherapy NL
Earnings Release Classification · 92% confidence The document is a press release dated March 5, 2013, announcing positive topline results from a Phase III study for the drug Vimpat (lacosamide) and stating that the company plans to submit this data to the FDA in the second half of 2013. It details clinical trial methodology, safety information, and product details for both US and EU markets. This content—announcing clinical trial results and future regulatory submission plans—is characteristic of an Earnings Release (ER) or a general press release regarding clinical/product news. Since it focuses on announcing key results rather than providing a comprehensive financial overview (like a 10-K or IR), and it is not a transcript (CT) or a formal presentation (IP), the most fitting category for a major, period-specific announcement of clinical/business progress is the Earnings Release (ER), which often includes such operational highlights alongside financial figures (though financials are not the focus here, the structure is typical of an ER press release). Given the context of UCB announcing clinical trial success and future regulatory filings, it functions as a significant business update, aligning best with ER, or potentially RNS if it were purely regulatory, but ER covers key operational announcements well. Q1 2013
2013-03-05 Dutch
2012_Annual_Report _ENG.pdf
Annual Report Classification · 100% confidence The document is a comprehensive annual report for UCB, containing a letter to stakeholders, management reports, consolidated financial statements, notes to financial statements, and performance reviews for the fiscal year 2012. It includes detailed financial tables, R&D milestones, and corporate governance information, which aligns with the definition of an Annual Report (10-K). FY 2012
2013-02-27 English
2012_Annual_Report_FR.pdf
Governance Information Classification · 100% confidence The document is extensive (nearly 700,000 characters) and contains a detailed Table of Contents listing sections like 'Rapport de gestion du Conseil d'Administration' (Management Report), 'Rapport financier' (Financial Report), 'États Financiers Consolidés' (Consolidated Financial Statements), and 'Rapport du commissaire aux comptes' (Auditor's Report). It also includes key financial figures spanning multiple years (2008-2012), detailed product pipelines, management changes, and a 'Lettre aux parties prenantes' (Letter to Stakeholders) discussing the full year's performance and outlook. The presence of consolidated financial statements, management discussion, and the auditor's report strongly indicates this is the comprehensive annual filing. Given the structure and content, this document is classified as an Annual Report (10-K equivalent for a non-US filer, but matching the scope of a 10-K). The language is French, but the content aligns perfectly with the definition of a 10-K, which is the official yearly report covering company activity and full financial performance.
2013-02-27 French
2012_Annual_Report_NL.pdf
Annual Report Classification · 100% confidence The document is a comprehensive annual report for UCB, containing a management report, consolidated financial statements, notes to the financial statements, corporate governance details, and performance highlights for the fiscal year 2012. It is clearly a full annual report rather than an announcement or a summary, as it includes detailed financial tables, operational reviews, and auditor reports. FY 2012
2013-02-27 Dutch
UCB_ResultsFY2012_en.pdf
Earnings Release Classification · 98% confidence The document is explicitly titled as an announcement of 'consolidated 2012 financial results' released on February 27, 2013. It contains key financial highlights (Revenue, EBITDA, Net Profit, EPS) for the full year 2012, an outlook for 2013, and details on R&D progress. This structure—a press release summarizing annual performance with key figures and forward guidance—is characteristic of an Earnings Release (ER). While it contains detailed financial tables, the primary format is a press release announcing the results, not the comprehensive, audited 10-K filing itself, nor is it a standalone Audit Report (AR). It is too detailed and comprehensive for just a Fund Factsheet (FS) and is not a transcript (CT) or a presentation (IP). The document itself states, 'A full financial report on the consolidated results is available on the UCB website,' suggesting this document is the initial announcement, fitting the ER definition best. FY 2012
2013-02-27 English
UCB_ResultsFY2012_fr.pdf
Annual Report Classification · 95% confidence The document provides a detailed summary of UCB's 2012 financial performance, including revenue, EBITDA, net income, R&D updates, and future outlook. While it mentions that the full financial report is available on their website, the document itself contains substantive financial data, tables, and management analysis of the fiscal year. It is not merely an announcement of a report, but a comprehensive summary of the annual results, fitting the definition of an Annual Report (10-K) or a comprehensive financial summary of the year. FY 2012
2013-02-27 French

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.